FCM
RCEL icon

Farallon Capital Management’s Avita Medical RCEL Stock Holding History

Farallon Capital Management’s Portfolio RCEL Stock Details RCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-580,000
Closed -$2.75M – 321
2022
Q2 		$2.75M Sell
580,000
-220,000
-28% -$1.36M 0.02% 201
2022
Q1 		$6.78M Hold
800,000
– – 0.04% 171
2021
Q4 		$9.58M Hold
800,000
– – 0.05% 135
2021
Q3 		$14.2M Hold
800,000
– – 0.08% 122
2021
Q2 		$16.4M Hold
800,000
– – 0.08% 107
2021
Q1 		$15.9M Buy
+800,000
New +$18.6M 0.08% 113

Other funds holding RCEL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $4.21B AUM 35.27% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $431B AUM 30.22% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $2.1B AUM 70.99% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return